日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A multi-omics approach reveals impaired lipid metabolism and oxidative stress in a zebrafish model of Alexander disease

多组学方法揭示了亚历山大病斑马鱼模型中脂质代谢受损和氧化应激。

Deianira Bellitto ,Matteo Bozzo ,Silvia Ravera ,Nadia Bertola ,Francesca Rosamilia ,Jessica Milia ,Paola Barboro ,Gabriela Coronel Vargas ,Donatella Di Lisa ,Laura Pastorino ,Francesca Lantieri ,Patrizio Castagnola ,Erika Iervasi ,Marco Ponassi ,Aldo Profumo ,Kateryna Tkachenko ,Camillo Rosano ,Simona Candiani ,Tiziana Bachetti

Long-term benefits of TUDCA supplement in ARSACS zebrafish model

TUDCA补充剂对ARSACS斑马鱼模型的长期益处

Naef, Valentina; Vecchia, Stefania Della; Giacich, Michela; Licitra, Rosario; Bachetti, Tiziana; Vargas, Gabriela Coronel; Ponassi, Marco; Santorelli, Filippo Maria

Antiprotozoal Activity of Highly Substituted Pyrazole and Pyrimidine Derivatives

高取代吡唑和嘧啶衍生物的抗原生动物活性

Lusardi, Matteo; Basilico, Nicoletta; Iervasi, Erika; Brullo, Chiara; Parapini, Silvia; Ponassi, Marco; Rosano, Camillo; Spallarossa, Andrea

Targeting Ubiquitin-Specific Protease 7 with Novel 5-Amino-Pyrazole Inhibitors: Design, Synthesis, and Biological Evaluation

利用新型5-氨基吡唑抑制剂靶向泛素特异性蛋白酶7:设计、合成和生物学评价

Lusardi, Matteo; Morretta, Elva; Spallarossa, Andrea; Chiara Monti, Maria; Rosano, Camillo; Iervasi, Erika; Ponassi, Marco; Mori, Matteo; Meneghetti, Fiorella; Brullo, Chiara

Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology

Fraisinib:一种杯吡咯衍生物,可在体内减少 A549 细胞衍生的 NSCLC 肿瘤,并充当甘氨酸-tRNA 合酶的配体,这是肿瘤学中的一种新分子靶点

Iméne Ben Toumia #, Tiziana Bachetti #, Leila Chekir-Ghedira, Aldo Profumo, Marco Ponassi, Alessandro Di Domizio, Alberto Izzotti, Salvatore Sciacca, Caterina Puglisi, Stefano Forte, Raffaella Giuffrida, Cristina Colarossi, Danilo Milardi, Giuseppe Grasso, Valeria Lanza, Stefano Fiordoro, Giacomo Dr

Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole Derivatives

5-氨基吡唑衍生物抗氧化及抗癌活性研究

Federica Rapetti, Andrea Spallarossa, Eleonora Russo, Debora Caviglia, Carla Villa, Bruno Tasso, Maria Grazia Signorello, Camillo Rosano, Erika Iervasi, Marco Ponassi, Chiara Brullo

A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo-Pyrazole Treatment in SKMEL-28 Melanoma Cells

蛋白质组学方法确定 RREB1 是 SKMEL-28 黑色素瘤细胞中咪唑并吡唑治疗的关键分子靶点

Erika Iervasi, Gabriela Coronel Vargas, Tiziana Bachetti, Kateryna Tkachenko, Andrea Spallarossa, Chiara Brullo, Camillo Rosano, Sonia Carta, Paola Barboro, Aldo Profumo, Marco Ponassi

Mono- and di-acylated imidazolidine-2-thione derivatives: synthesis, cytotoxicity evaluation and computational studies

单酰化和双酰化咪唑烷-2-硫酮衍生物:合成、细胞毒性评价和计算研究

Anna Scarsi, Marco Ponassi, Chiara Brullo, Camillo Rosano, Andrea Spallarossa

Lipid Metabolism Reprogramming and Trastuzumab Resistance in Breast Cancer Cell Lines Overexpressing the ERBB2 Membrane Receptor

过表达 ERBB2 膜受体的乳腺癌细胞系中的脂质代谢重编程和曲妥珠单抗耐药性

Katia Cortese, Marco Ponassi, Aldo Profumo, Gabriela Coronel Vargas, Erika Iervasi, Maria Cristina Gagliani, Grazia Bellese, Sara Tavella, Patrizio Castagnola

A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients

基于 Exo-miR-130a-3p 和纤维蛋白肽 A 联合表达的循环风险评分作为可切除非小细胞肺癌患者复发的预测生物标志物

Silvia Marconi, Michela Croce, Giovanna Chiorino, Giovanni Rossi, Francesca Guana, Aldo Profumo, Paola Ostano, Angela Alama, Luca Longo, Giuseppa De Luca, Mariella Dono, Maria Giovanna Dal Bello, Marco Ponassi, Camillo Rosano, Paolo Romano, Zita Cavalieri, Massimiliano Grassi, Marco Tagliamento, Lod